All In MedTech

Device Trial Radar · NCT06812533

Alleviant ALLAY-HFrEF Study

Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

Mar 10, 2025

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Alleviant Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 6, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.

Conditions

  • Heart Failure

Interventions

  • Alleviant ALV1 SystemDevice

    Creation of interatrial shunt

  • Sham-ControlOther

    Cardiac imaging

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Primary EndpointTime frame: 12-Month

Locations

70 sites in 11 countries. Site status is shown where the registry gives one.

  • Keck Medical Center of USC

    Los Angeles, California · Recruiting

  • University California Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • UC Davis Medical Center

    Sacramento, California · Recruiting

67 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.